Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|November 8, 2006
Modulation of cyclic nucleotides and cyclic nucleotide phosphodiesterases in pancreatic islet beta-cells and intestinal L-cells as targets for treating diabetes mellitusBrian Furman, Nigel PyneAdvances in Experimental Medicine and Biology|March 11, 2010
Cyclic AMP signaling in pancreatic isletsBrian Furman, Wee Kiat Ong, Nigel J PyneThe Journal of Pharmacy and Pharmacology|November 27, 2004
Targeting beta-cell cyclic 3'5' adenosine monophosphate for the development of novel drugs for treating type 2 diabetes mellitus. A reviewBrian Furman, Nigel Pyne, Peter Flatt, et al.The Journal of Pharmacy and Pharmacology|July 4, 2023
Effect of madecassoside in reducing oxidative stress and blood glucose in streptozotocin-nicotinamide-induced diabetes in ratsSwee Ching Tan, Ramkumar Rajendran, Subrat Kumar Bhattamisra, et al.Natural Product Research|February 10, 2024
Protective effects of madecassoside, a triterpenoid from Centella asiatica, against oxidative stress in INS-1E cellsSwee Ching Tan, Ramkumar Rajendran, Subrat Kumar Bhattamisra, et al.Pageof 1